FDA Drug · D-0602-2024

Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-10

Class II · Completed

Failed Impurities/Degradation Specifications

Affected lots / codes — check yours against thisLot #: 8147040; Exp. June 2024 Lot #: 8163764; Exp. March 2025

Recalling firm: Viatris Inc, Canonsburg, PA
Classification: Class II (temporary or reversible harm possible)
Status: Completed
Quantity: 12,691 bottles
Distribution: U.S. Nationwide
Recall initiated: April 30, 2024
Classified: July 16, 2024
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0602-2024%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →